Improving how the FDA disseminates already-public information about approved drugs may be unsexy, but it would be a big step ...

The DCGI has directed state and UT drug controllers to monitor levels of the potentially carcinogenic NDMA in Ranitidine, an ...

Several high-ranking members of the National Multi-Sectorial Steering Committee tasked with combating illicit drugs in ...

President Donald Trump has thrown his support behind Florida state Sen. Joe Gruters (R)—a vocal proponent of marijuana ...

A top U.S. health lobbying group is calling on Health Secretary Robert F. Kennedy Jr. to not dismiss a preventive task force following a report he’s planning to remove all of its members in ...

The US Food and Drug Administration recently convened a panel of experts to examine a sensitive and increasingly urgent ...

Last Monday, an expert panel convened by the U.S. Food and Drug Administration (FDA) to discuss the use of selective ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.

A notorious drug dealer who was recently released on bail by the Federal High Court in Kano, Suleiman Danwawu, has allegedly ...

A key House committee is looking into the investigation of the late Jeffrey Epstein for sex trafficking crimes, working to ...